Design and synthesis of a few novel methylamino piperidinyl substituted oxazolidinones are reported. Their antibacterial activities have been evaluated in a MIC assay against broader panel of both susceptible and resistant Gram-positive strains. (
S)-
N-{3-[3-Fluoro-4-(methyl-{1-[3-(5-nitrofuran-2-yl)-acryloyl]-piperidin-4-yl}-amino)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide
4i has shown comparable antibacterial activity to linezolid and eperezolid in the MIC assay, additionally compound
4i showed good antibacterial activity with an in vitro MIC value of 2–4 μg/mL against linezolid resistant
Staphylococcus aureus (linezolid
![]()
16 μg/mL).